Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016604
Filing Date
2022-11-07
Accepted
2022-11-07 16:04:05
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20220930x10q.htm   iXBRL 10-Q 1676646
2 EX-10.3 mrns-20220930xex10d3.htm EX-10.3 999234
3 EX-10.4 mrns-20220930xex10d4.htm EX-10.4 287816
4 EX-10.5 mrns-20220930xex10d5.htm EX-10.5 132217
5 EX-31.1 mrns-20220930xex31d1.htm EX-31.1 13245
6 EX-31.2 mrns-20220930xex31d2.htm EX-31.2 13354
7 EX-32.1 mrns-20220930xex32d1.htm EX-32.1 7679
8 GRAPHIC mrns-20220930x10q004.jpg GRAPHIC 14134
9 GRAPHIC mrns-20220930x10q007.jpg GRAPHIC 102003
  Complete submission text file 0001558370-22-016604.txt   8577779

Data Files

Seq Description Document Type Size
10 EX-101.SCH mrns-20220930.xsd EX-101.SCH 51149
11 EX-101.CAL mrns-20220930_cal.xml EX-101.CAL 55166
12 EX-101.DEF mrns-20220930_def.xml EX-101.DEF 185581
13 EX-101.LAB mrns-20220930_lab.xml EX-101.LAB 428599
14 EX-101.PRE mrns-20220930_pre.xml EX-101.PRE 309208
60 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20220930x10q_htm.xml XML 1071686
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 221365372
SIC: 2834 Pharmaceutical Preparations